Column: Did drug makers really stand up to Trump over those ‘Trump card’ discounts? Doubtful
Los Angeles Times
September 21, 2020, 12:36 pm
Few industries have a harder time securing positive PR than America’s drug makers. So you should take with a heap of salt the recent report about how they took a moral stand against President Trump. According to the report in the New York Times the industry was on the verge of agreeing to reduce consumer drug costs by $150 billion until the Trump White House went a step too far.
